WellGen to use $9.5mn financing to fund pipeline
Nutrigenomics researcher WellGen has announced the completion of a Series C financing worth $9.5mn it plans to use to build a pipeline of patented nutraceuticals.
News, Analysis & Insights on Nutrition, Supplements, and Health
Nutrigenomics researcher WellGen has announced the completion of a Series C financing worth $9.5mn it plans to use to build a pipeline of patented nutraceuticals.
Increasingly complicated product labels do not seem to have scared consumers off, according to a new report that revels that more Americans are likely to read food and beverage product labels today than they were a year ago.
Sabinsa Corporation says it has received independent GRAS status for the use of its flagship proprietary ingredient CitrinK in functional beverages.